Immuron Ltd ADR (IMRN) Stock Price, Quote & News

Company Profile

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune su...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9824 5254

Fax: 61 3 9822 7735

Website: www.immuron.com.au

Address:

62 Lygon Street, Level 3 Carlton South, Carlton, Australia

Baazigar30 Jul. 7 at 10:05 PM

$IMRN Float & OS: 3.82M/ 5.84 My target $10 Do your own DD imo

0 · Reply

Baseball89 Jun. 30 at 8:14 PM

$NCNA $IMRN what is going on with this stock? Its spiked today. Any news? Is this one waking up?

0 · Reply

Baseball89 Jun. 26 at 6:43 PM

$CYN $IMRN ---very good technicals Let's get this one moving. Hot!

0 · Reply

twisrs Jun. 26 at 6:33 PM

$BIAF $ASTI $CYN $VOR i like $IMRN needs volume I'm buying here

0 · Reply

Baseball89 Jun. 26 at 6:00 PM

$MKDW $IMRN has low float. Let's get this thing moving. Solid. Double corporate earnings, military 🪖 contracts,revenue growth

0 · Reply

Baseball89 Jun. 26 at 5:51 PM

$CYN $IMRN ---low float hello.. you seeing this.

0 · Reply

Baseball89 Jun. 26 at 5:32 PM

$CYN I'm banking on $IMRN . Getting in early on this one.

1 · Reply

Baseball89 Jun. 26 at 5:25 PM

$CYN $IMRN could be the next one.

0 · Reply

Baseball89 Jun. 26 at 1:04 PM

$BDRX $IMRN ..... This one looks solid. Continue quarterly revenue growth. This one needs some traction. Shares are cheap. US military contract... Travelan

1 · Reply

Baseball89 Jun. 26 at 10:58 AM

$NCNA $IMRN ---this one looks solid. Keep on your radar. Continued revenue growth per quarter.

0 · Reply

Immuron Letter to Shareholders: Projects Update

Apr 10, 2025, 6:00 PM EDT - 3 months ago

Immuron Travelan® highest sales in history

Mar 5, 2025, 6:00 AM EST - 4 months ago

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Jan 17, 2025, 6:00 AM EST - 6 months ago

Immuron Travelan® continued strong sales growth

Jan 15, 2025, 6:00 AM EST - 6 months ago

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Jan 14, 2025, 6:00 AM EST - 6 months ago

Immuron Announces Travelan® Clinical Trial Update

Dec 2, 2024, 6:00 AM EST - 7 months ago

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Nov 21, 2024, 6:33 PM EST - 8 months ago

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

Nov 18, 2024, 8:30 AM EST - 8 months ago

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

Oct 16, 2024, 6:00 AM EDT - 9 months ago

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

Oct 4, 2024, 6:30 AM EDT - 9 months ago

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Sep 19, 2024, 9:42 AM EDT - 10 months ago

Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma

Sep 5, 2024, 11:54 AM EDT - 10 months ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Aug 20, 2024, 7:00 AM EDT - 11 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS GOVX

Aug 16, 2024, 6:00 AM EDT - 11 months ago

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

Aug 15, 2024, 6:14 PM EDT - 11 months ago

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Aug 7, 2024, 6:00 AM EDT - 11 months ago

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

Jul 2, 2024, 6:00 AM EDT - 1 year ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron Board Changes

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore to present at Peak Sky High

May 7, 2024, 6:00 AM EDT - 1 year ago

Immuron Limited to Present at the Emerging Growth Conference

May 3, 2024, 6:00 AM EDT - 1 year ago

Immuron Director Resignation

Apr 15, 2024, 6:00 AM EDT - 1 year ago

Immuron to host Live Virtual Event

Apr 10, 2024, 6:00 AM EDT - 1 year ago

Immuron Travelan® sales continued strong growth

Mar 7, 2024, 6:00 AM EST - 1 year ago

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Feb 21, 2024, 6:00 AM EST - 1 year ago

Immuron Presentation Australian Biologics Festival 2024

Feb 13, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record Travelan® sales

Feb 8, 2024, 6:00 AM EST - 1 year ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Jan 16, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record half yearly Travelan® sales

Dec 22, 2023, 6:00 AM EST - 1 year ago

Immuron Clinical Trials Update

Dec 4, 2023, 6:00 AM EST - 1 year ago

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

Nov 13, 2023, 6:00 PM EST - 1 year ago

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Oct 30, 2023, 7:21 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore presented at AusBioInvest

Oct 18, 2023, 6:00 AM EDT - 1 year ago

Immuron Announces Travelan® Clinical Study Cohort 2 commences

Oct 11, 2023, 6:00 AM EDT - 1 year ago

Immuron achieves record quarterly Travelan® sales

Sep 18, 2023, 7:30 AM EDT - 1 year ago

Immuron Limited Announces Participation in the LD Micro Main Event XVI

Sep 13, 2023, 6:00 AM EDT - 1 year ago

Immuron achieves record monthly Travelan® sales

Sep 11, 2023, 6:00 AM EDT - 1 year ago

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

Aug 14, 2023, 6:00 AM EDT - 2 years ago

Immuron to present at the Military Health System Research Symposium

Jul 25, 2023, 6:00 AM EDT - 2 years ago

Immuron Announces First Patients Enrolled in Travelan® Clinical Study

Jul 24, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at Bioshares

Jul 11, 2023, 6:00 AM EDT - 2 years ago

Immuron Business Update - Ateria Health launches Juvia™ in Australia

Jul 5, 2023, 6:00 AM EDT - 2 years ago

Immuron FY23 Sales increase 136% on FY22 Sales

Jun 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Chairman Transition

Jun 22, 2023, 6:00 AM EDT - 2 years ago

Immuron Business Update: Letter to Shareholders

May 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Initiates Recruitment of Travelan® Clinical Study

May 16, 2023, 7:30 AM EDT - 2 years ago

Immuron Limited Announces Participation in the LD Micro Invitational XIII

May 8, 2023, 6:35 AM EDT - 2 years ago

Immuron stock rockets after FDA removes hold on IND of infectious diarrhea treatment

May 8, 2023, 6:00 AM EDT - 2 years ago

Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation

May 2, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at Coffee Microcaps

Baazigar30 Jul. 7 at 10:05 PM

$IMRN Float & OS: 3.82M/ 5.84 My target $10 Do your own DD imo

0 · Reply

Baseball89 Jun. 30 at 8:14 PM

$NCNA $IMRN what is going on with this stock? Its spiked today. Any news? Is this one waking up?

0 · Reply

Baseball89 Jun. 26 at 6:43 PM

$CYN $IMRN ---very good technicals Let's get this one moving. Hot!

0 · Reply

twisrs Jun. 26 at 6:33 PM

$BIAF $ASTI $CYN $VOR i like $IMRN needs volume I'm buying here

0 · Reply

Baseball89 Jun. 26 at 6:00 PM

$MKDW $IMRN has low float. Let's get this thing moving. Solid. Double corporate earnings, military 🪖 contracts,revenue growth

0 · Reply

Baseball89 Jun. 26 at 5:51 PM

$CYN $IMRN ---low float hello.. you seeing this.

0 · Reply

Baseball89 Jun. 26 at 5:32 PM

$CYN I'm banking on $IMRN . Getting in early on this one.

1 · Reply

Baseball89 Jun. 26 at 5:25 PM

$CYN $IMRN could be the next one.

0 · Reply

Baseball89 Jun. 26 at 1:04 PM

$BDRX $IMRN ..... This one looks solid. Continue quarterly revenue growth. This one needs some traction. Shares are cheap. US military contract... Travelan

1 · Reply

Baseball89 Jun. 26 at 10:58 AM

$NCNA $IMRN ---this one looks solid. Keep on your radar. Continued revenue growth per quarter.

0 · Reply

Baseball89 Jun. 26 at 10:48 AM

$IMRN who is quietly loading here? Low float. Look solid

0 · Reply

DipRipper33 Jun. 24 at 3:37 PM

$IMRN

0 · Reply

NextBigRun Jun. 20 at 2:39 AM

GLMD is sitting on a launchpad. Under cash, no debt, real GLP-1/fibrosis catalysts, and a float that already sent it to $2.08 without news. The setup is rare and it’s ready. $SHPH $TRVN $IMRN $TIVC

0 · Reply

YasirTrades Jun. 20 at 2:27 AM

GLMD is the sleeper play of the year. Trading below cash, zero debt, real biotech catalysts ahead, and a float that already pushed it to $2.08. When eyes return, this could ignite fast. $PHGE $IMRN $VTAK $PRSO

0 · Reply

YasirTrades Jun. 18 at 2:16 PM

GLMD is a ticking time bomb 💣 Trading under cash. $20+ book. No debt. Tiny float. GLP-1 catalyst loading. Chart is coiled tight. When volume hits… boom 💥 100%+ upside? That might be conservative. $TRVI, $LUNR, $IMRN, $RNXT ..

0 · Reply

GreenResearchers Jun. 16 at 9:52 AM

GLMD is a powder keg ready to blow. Trading under cash with a $20+ book value, no debt, and a tiny float this isn’t just undervalued, it’s insanely mispriced. The chart is tightening, momentum is building, and massive GLP-1 obesity + fibrosis catalysts are around the corner. This sector has sent names flying 500%+… GLMD hasn’t even started. When the spark hits volume, PR, or smart money rotation this could rip like wildfire. One of the cleanest high-upside setups on the entire market right now. $ATNF, $OPGN, $ACXP, $IMRN 🌙

0 · Reply

Baseball89 Jun. 10 at 10:11 AM

$LAES $BURU $IMRN --a sleeper $GPUS $FAAS Way undervalued

0 · Reply

Baseball89 Jun. 10 at 9:36 AM

$MLGO $IMRN ---this is asleeper about to wake up

0 · Reply

twisrs Jun. 2 at 2:24 PM

$IMRN $2 soon!

0 · Reply

Baseball89 Jun. 2 at 11:34 AM

$SBET $GPUS , $LAES $IMRN

0 · Reply

Baseball89 Jun. 2 at 9:57 AM

$BMGL $IMRN ---no reverse splits, increased corporate earnings. Looks solid. Keep on watch.

0 · Reply

delvanbeyond Jun. 1 at 1:08 PM

$IMRN 📈📈📈

0 · Reply

Market Cap	10.38M
Revenue (ttm)	3.22M
Net Income (ttm)	-4.55M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-141.30%
Debt to Equity Ratio	0.00

Volume	6,100
Avg Vol	33,786
Day's Range	N/A - N/A
Shares Out	5.85M
Stochastic %K	54%
Beta	0.82
Analysts	Strong Sell
Price Target	$5.00